Ambreen Gul1, Dana Miskulin, Jennifer Gassman, Antonia Harford, Bruce Horowitz, Joline Chen, Susan Paine, Edward Bedrick, John W Kusek, Mark Unruh, Philip Zager. 1. Department of Medicine (AG, AH, BH, EB, PZ), University of New Mexico, Albuquerque, New Mexico; Department of Medicine (DM), Tufts University, Boston, Massachusetts; Department of Quantitative Health Sciences (JG), Cleveland Clinic Foundation, Cleveland, Ohio; Department of Medicine (JC), Boston University, Boston, Massachusetts; Dialysis Clinic, Inc (SP, PZ), Quality Management, Albuquerque, New Mexico; National Institutes of Health (JWK), NIDDK, Bethesda, Maryland; and Department of Medicine (MU), University of Pittsburgh, Pittsburgh, Pennsylvania.
Abstract
BACKGROUND:Cardiovascular disease (CVD) is markedly increased among hemodialysis (HD) patients. Optimizing blood pressure (BP) among HD patients may present an important opportunity to reduce the disparity in CVD rates between HD patients and the general population. The optimal target predialysis systolic BP (SBP) among HD patients is unknown. Current international guidelines, calling for a predialysis SBP < 140 mm Hg, are based on the opinion and extrapolation from the general population. Existing randomized controlled trials (RCTs) were small and did not include prespecified BP targets. METHODS: The authors described the design of the Blood Pressure in Dialysis (BID) Study, a pilot, multicenter RCT where HD patients are randomized to either a target-standardized predialysis SBP of 110 to 140 mm Hg or 155 to 165 mm Hg. This is the first study to randomize HD patients to 2 different SBP targets. RESULTS: Primary outcomes are feasibility and safety. Feasibility parameters include recruitment and retention rates, adherence with prescribed BP measurements and achievement and maintenance of selected BP targets. Safety parameters include rates of hypotension and other adverse and serious adverse events. The authors obtained preliminary data on changes in left ventricular mass, aortic pulse wave velocity, vascular access thromboses and health-related quality of life across study arms, which may be the secondary outcomes in the full-scale study. CONCLUSIONS: The data acquired in the pilot RCT will determine the feasibility and safety and inform the design of a full-scale trial, powered for hard outcomes, which may require 2000 participants.
RCT Entities:
BACKGROUND:Cardiovascular disease (CVD) is markedly increased among hemodialysis (HD) patients. Optimizing blood pressure (BP) among HDpatients may present an important opportunity to reduce the disparity in CVD rates between HDpatients and the general population. The optimal target predialysis systolic BP (SBP) among HDpatients is unknown. Current international guidelines, calling for a predialysis SBP < 140 mm Hg, are based on the opinion and extrapolation from the general population. Existing randomized controlled trials (RCTs) were small and did not include prespecified BP targets. METHODS: The authors described the design of the Blood Pressure in Dialysis (BID) Study, a pilot, multicenter RCT where HDpatients are randomized to either a target-standardized predialysis SBP of 110 to 140 mm Hg or 155 to 165 mm Hg. This is the first study to randomize HDpatients to 2 different SBP targets. RESULTS: Primary outcomes are feasibility and safety. Feasibility parameters include recruitment and retention rates, adherence with prescribed BP measurements and achievement and maintenance of selected BP targets. Safety parameters include rates of hypotension and other adverse and serious adverse events. The authors obtained preliminary data on changes in left ventricular mass, aortic pulse wave velocity, vascular access thromboses and health-related quality of life across study arms, which may be the secondary outcomes in the full-scale study. CONCLUSIONS: The data acquired in the pilot RCT will determine the feasibility and safety and inform the design of a full-scale trial, powered for hard outcomes, which may require 2000 participants.
Authors: V L Burt; P Whelton; E J Roccella; C Brown; J A Cutler; M Higgins; M J Horan; D Labarthe Journal: Hypertension Date: 1995-03 Impact factor: 10.190
Authors: Rajiv Agarwal; Allen R Nissenson; Daniel Batlle; Daniel W Coyne; J Richard Trout; David G Warnock Journal: Am J Med Date: 2003-09 Impact factor: 4.965
Authors: Garabed Eknoyan; Gerald J Beck; Alfred K Cheung; John T Daugirdas; Tom Greene; John W Kusek; Michael Allon; James Bailey; James A Delmez; Thomas A Depner; Johanna T Dwyer; Andrew S Levey; Nathan W Levin; Edgar Milford; Daniel B Ornt; Michael V Rocco; Gerald Schulman; Steve J Schwab; Brendan P Teehan; Robert Toto Journal: N Engl J Med Date: 2002-12-19 Impact factor: 91.245
Authors: Lynda A Szczech; Huiman X Barnhart; Jula K Inrig; Donal N Reddan; Shelly Sapp; Robert M Califf; Uptal D Patel; Ajay K Singh Journal: Kidney Int Date: 2008-07-02 Impact factor: 10.612
Authors: Mark J Sarnak; Andrew S Levey; Anton C Schoolwerth; Josef Coresh; Bruce Culleton; L Lee Hamm; Peter A McCullough; Bertram L Kasiske; Ellie Kelepouris; Michael J Klag; Patrick Parfrey; Marc Pfeffer; Leopoldo Raij; David J Spinosa; Peter W Wilson Journal: Circulation Date: 2003-10-28 Impact factor: 29.690
Authors: Amith Roy Shamir; Ameet Karembelkar; Jonathan Yabes; Yi Yao; Dana Miskulin; Jennifer Gassman; David Ploth; Lavinia Negrea; Susan Paine; Mahboob Rahman; Raymond Y Kwong; Philip Zager; Manisha Jhamb Journal: Kidney Blood Press Res Date: 2018-05-30 Impact factor: 2.687
Authors: Dana C Miskulin; Jennifer Gassman; Ronald Schrader; Ambreen Gul; Manisha Jhamb; David W Ploth; Lavinia Negrea; Raymond Y Kwong; Andrew S Levey; Ajay K Singh; Antonia Harford; Susan Paine; Cynthia Kendrick; Mahboob Rahman; Philip Zager Journal: J Am Soc Nephrol Date: 2017-12-06 Impact factor: 10.121
Authors: Nisha Bansal; Charles E McCulloch; Mahboob Rahman; John W Kusek; Amanda H Anderson; Dawei Xie; Raymond R Townsend; Claudia M Lora; Jackson Wright; Alan S Go; Akinlolu Ojo; Arnold Alper; Eva Lustigova; Magda Cuevas; Radhakrishna Kallem; Chi-Yuan Hsu Journal: Hypertension Date: 2014-10-06 Impact factor: 10.190
Authors: Nisha Bansal; Charles E McCulloch; Feng Lin; Arnold Alper; Amanda H Anderson; Magda Cuevas; Alan S Go; Radhakrishna Kallem; John W Kusek; Claudia M Lora; Eva Lustigova; Akinlolu Ojo; Mahboob Rahman; Cassianne Robinson-Cohen; Raymond R Townsend; Jackson Wright; Dawei Xie; Chi-Yuan Hsu Journal: Hypertension Date: 2017-07-03 Impact factor: 10.190
Authors: Tariq Shafi; Stephen M Sozio; Jason Luly; Karen J Bandeen-Roche; Wendy L St Peter; Patti L Ephraim; Aidan McDermott; Charles A Herzog; Deidra C Crews; Julia J Scialla; Navdeep Tangri; Dana C Miskulin; Wieneke M Michels; Bernard G Jaar; Philip G Zager; Klemens B Meyer; Albert W Wu; L Ebony Boulware Journal: Medicine (Baltimore) Date: 2017-02 Impact factor: 1.889
Authors: Mary C Mallappallil; Steven Fishbane; Rimda Wanchoo; Edgar Lerma; Andrea Roche-Recinos; Moro Salifu Journal: BMC Nephrol Date: 2018-06-22 Impact factor: 2.388
Authors: Dana C Miskulin; Huan Jiang; Ambreen Gul; V Shane Pankratz; Susan S Paine; Jennifer J Gassman; Manisha Jhamb; Raymond Y Kwong; Lavinia Negrea; David W Ploth; Saeed Kamran Shaffi; Antonia M Harford; Philip G Zager Journal: Am J Kidney Dis Date: 2021-06-16 Impact factor: 8.860